50
Participants
Start Date
August 1, 2025
Primary Completion Date
April 1, 2026
Study Completion Date
July 1, 2026
Institute of Human Virology, Nigeria, Abuja
National Cancer Institute (NCI)
NIH
University of Witwatersrand, South Africa
OTHER
Yale University
OTHER